Loading
Total declarations
Companies
▲ Purchases (7 ops.)
▼ Sales (0 ops.)
Latest filing published 21 Nov 2014 for UROLOGIX INC.
Insider track record
Disclosed buys
7
Disclosed sells
0
Signal history
No signal scores available.
Closed purchases
Market purchases
7
Positive at T+90
0%
Median T+90
-13.9%
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -50.0%Entry 0.36 · Close at T+365 0.18
- -56.6%Entry 0.83 · Close at T+365 0.36
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Mitchell Dann: trading record in brief
Mitchell Dann has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Urologix Inc and Trans1 Inc. We count 24 filings; the first trade dates from 22 October 2007 and the latest from 6 November 2014.
Purchases make up the whole of the open-market record (7 purchases, €194k). Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 11 share grants and 3 option exercises.
In size, the median ticket on the buying side is €29k.
The record was last updated on 21 November 2014 with a share grant in Urologix Inc. The latest purchase dates back some time: it was published 4,848 days ago, on 15 July 2013. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Mitchell Dann
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations21 total
45,455 shares0Common StockSEC:0001615594-14-000017:0
50,000 shares0Common StockSEC:0001362118-14-000010:0
20,000 shares@ US$0.30Common StockSEC:0001362118-13-000082:0
Canonical exit: 10 Oct 2013 (T+90)
26,516 shares0Common StockSEC:0001262014-12-000005:0
100,000 shares@ US$0.75Common StockSEC:0001362118-12-000095:0
Canonical exit: 27 Sept 2012 (T+90)
18,042 shares0Common StockSEC:0001362118-11-000097:0
15,244 shares0Common StockSEC:0001484321-10-000003:0
12,500 shares@ US$2.95Common StockSEC:0001209191-10-030950:0
Canonical exit: 25 Aug 2010 (T+90)
21,666 shares0Common StockSEC:0001262014-09-000021:0
21,666 shares0Common StockSEC:0001262014-09-000021:1
8,774 shares0Common StockSEC:0001362118-09-000039:0
10,800 shares@ US$4.00Common StockSEC:0001209191-09-051049:0
Canonical exit: 1 Feb 2010 (T+90)
1,700 shares@ US$4.01Common StockSEC:0001209191-09-051049:1
Canonical exit: 2 Feb 2010 (T+90)
10,000 shares@ US$0.79Common StockSEC:0001262014-08-000044:0
6,000 shares@ US$6.38Common StockSEC:0001209191-08-063819:0
6,500 shares@ US$8.57Common StockSEC:0001209191-08-049382:0
10,000 shares@ US$0.78Common StockSEC:0001262014-08-000034:0
40,000 shares@ US$0.78Common StockSEC:0001262014-08-000034:1
3,600 shares@ US$9.88Common StockSEC:0001209191-08-017015:0
3,000 shares@ US$12.75Common StockSEC:0001209191-08-015969:0
1,588,090 sharesCommon StockSEC:0001209191-07-059509:0
21 of 21 declarations
